---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "NZoNGGFxl6n4pFvg6hKRtvLY36nTr+bFYcRi4prEgiU4J6AOu6TQjEMLymxcuF5Y27p916C51sSYB2vyQlX2/r5pGElkekcCX0+j/cv/UPx5I8uqYQnuqiJ1IQeD0recsA2DG9E0tG+R47KvpFCqJPHi7GPxNk7zSlnv2IlUL/qd2fm6l9YMoXFI8N/ZSANEOY/p5iuBFEzQ3XKiEYH9EKIRXT6bC9GpwSuKLw07jSo2K+lT/BkTwv8hvZawEm/qASK/xw+UUdTVo0D663vs0ewSRhnP0TWCg09RlXojKRzu8UgeDfsXYZ1xM2TSPdhr;jl95KqN+Bvgl3egQDVvfwg=="
---

